Diabetes Research and Clinical Practice
Volume 74, Issue 2 , Pages 162-168 , November 2006

Predictors of incident diabetes, metabolic syndrome in middle-aged adults: A 10-year follow-up study from Kinmen, Taiwan

  • Wayne Huey-Herng Sheu

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, ROC
    • ,
  • Shao-Yuan Chuang

      Affiliations

    • Institute of Public Health, Community Medicine Research Center, National Yang-Ming University, Taiwan, ROC
    • ,
  • Wen-Jane Lee

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, ROC
    • ,
  • Shih-Tzer Tsai

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC
    • ,
  • Pesus Chou

      Affiliations

    • Institute of Public Health, Community Medicine Research Center, National Yang-Ming University, Taiwan, ROC
    • ,
  • Chen-Huan Chen

      Affiliations

    • Department of Social Medicine, National Yang-Ming University, Taipei, Taiwan, ROC
    • Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei, Taiwan, ROC
    • Corresponding Author InformationCorresponding author at: Department of Medical Research and Education, No. 201, Sec. 2, Shih-Pai Road, Taipei Veterans General Hospital, Taipei, Taiwan, ROC. Tel.: +866 2 28712121x2073; fax: +886 2 28717431.

Received 20 November 2005 ,Accepted 15 March 2006.

References 

  1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M . Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 1998;339:229–234
  2. Reaven GM Banting lecture. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–1607
  3. Organization H. (1999) Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Geneva, World Health Organization.
  4. Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001) JAMA 285:2486–2497.
  5. Isomaa B, Henricsson M, Almgren P, Tuomi T, Taskinen MR, Groop L. The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia. 2001;44:1148–1154
  6. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–2716
  7. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110:1245–1250
  8. Palaniappan L, Carnethon MR, Wang Y. Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2004;27:788–793
  9. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III participants age 50 years and older. Diabetes. 2003;52:1210–1214
  10. Bonora E, Targher G, Formentini G, et al. Prospective data from the Verona Diabetes Complications Study. The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Diabetes Med. 2004;21:52–58
  11. Han TS, Williams K, Sattar N, Hunt KJ, Lean MEJ, Haffner SM. Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Obes. Res. 2002;10:923–931
  12. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care. 2003;26:3153–3159
  13. Sattar N, Gaw A, Scherbakova O, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003;108:414–419
  14. Chen CH, Chuang JH, Kuo HS, Chang MS, Wang SP, Chou P. A population-based epidemiological study on cardiovascular risk factors in Kin-Chen, Kinmen. Int. J. Cardiol. 1995;48:75–88
  15. Chen CH, Lin KC, Tsai ST, Chou P. Different association of hypertension and insulin-related metabolic syndrome between men and women in 8437 nondiabetic Chinese. Am. J. Hypertens. 2000;13:846–853
  16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  17. Tan C-E, Ma S, Wai D, Chew S-K, Tai E-S. Can we apply the national cholesterol education program adult treatment panel definition of the metabolic syndrome to Asians. Diabetes Care. 2004;27:1182–1186
  18. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183–1197.
  19. Tseng CH, Chong CK, Heng LT, Tseng CP, Tai TY. The incidence of type 2 diabetes mellitus in Taiwan. Diabetes Res. Clin. Pract. 2000;50(2):S61–S64
  20. Palaniappan L, Carnethon MR, Wang Y, et al. Predictors of the incident metabolic syndrome in adults: the insulin resistance atherosclerosis study. Diabetes Care. 2004;27:788–793
  21. Carnethon MR, Loria CM, Hill JO, Sidney S, Savage PJ, Liu K. Risk factors for the metabolic syndrome: the coronary artery risk development in young adults (CARDIA) study, 1985–2001. Diabetes Care. 2004;27:2707–2715
  22. Chou P, Li C, Wu G, Tsai S. Progression to type 2 diabetes among high-risk groups in Kin-Chen. Kinmen. Exploring the natural history of type 2 diabetes. Diabetes Care. 1998;21:1183–1187
  23. Wang JJ, Qiao O, Miettinen ME, Lappalainen J, Hu G, Tuomilehto J. The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a Chinese population with high postprandial glucose. Diabetes Care. 2004;27:2429–2437
  24. Lorenzo C, Serrano-Rios M, Martinez-Larrad Mt, et al. Central adiposity determines prevalence differences of the metabolic syndrome. Obes. Res. 2003;11:1480–1487
  25. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care. 2003;26:575–581
  26. Meigs JB, Wilson PW, Nathan DM, D’Agostino RB, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio heart and Framingham offspring studies. Diabetes. 2003;52:2160–2167
  27. Alberti KGG, Zimmet PZ, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366:1059–1062
  28. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415–1428

PII: S0168-8227(06)00112-4

doi: 10.1016/j.diabres.2006.03.011

Diabetes Research and Clinical Practice
Volume 74, Issue 2 , Pages 162-168 , November 2006

Article Tools

* Image Usage & Resolution